A Phase II, Randomised, Multi-Centre Study of Cabazitaxel Versus Abiraterone or Enzalutamide in Poor Prognosis-Metastatic Castration-Resistant Prostate Cancer

Project: Research

Project Description

NMA Reference Number: HREC/16/MonH/165
Monash Health HREC Ref: 16-266A

StatusActive
Effective start/end date4/01/193/01/24